Recoverability of Erectile Function in Post–Radical Cystectomy Patients: Subjective and Objective Evaluations

Walsh, 1982, Impotence following radical prostatectomy: insight into etiology and prevention, J Urol, 128, 492, 10.1016/S0022-5347(17)53012-8 Schlegel, 1987, Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function, J Urol, 138, 1402, 10.1016/S0022-5347(17)43655-X Chiang, 1997, Nerve-sparing radical cystoprostatectomy: 3-year experience, Kaohsiung J Med Sci, 13, 169 Miyao, 2001, Recovery of sexual function after nerve- sparing radical prostatectomy or cystectomy, Int J Urol, 8, 158, 10.1046/j.1442-2042.2001.00274.x Taniguchi, 2002, Voiding function and sexual activity in patient following Hautmann neobladder construction, Nippon HinyoKika Gakkai Zasshi, 93, 694 Martis, 2005, Prostatic capsule- and nerve-sparing cystectomy in organ-confined bladder cancer: preliminary results, World J Surg, 29, 1277, 10.1007/s00268-005-7852-7 Zippe, 2004, Sexual function after male radical cystectomy in a sexually active population, Urology, 64, 682, 10.1016/j.urology.2004.05.056 Beckendorf, 1996, Changes in sexual function after radiotherapy treatment of prostate cancer, BJU, 77, 118, 10.1046/j.1464-410X.1996.81920.x Catalona, 1999, Potency, continence, and complication rates in 1,870 consecutive radical retropubic prostatectomies, J Urol, 162, 433, 10.1016/S0022-5347(05)68578-3 Mulcahy, 2000, Erectile function after radical prostatectomy, Semin Urol Oncol, 18, 71 Rosen, 1997, The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0 Zorgniotti, 1985, Autoinjection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence, J Urol, 133, 139, 10.1016/S0022-5347(17)48774-X Schwartz, 1992, Radiographic diagnosis and treatment of erectile dysfunction, Urology, 2, 39 Knispel, 1992, Color-coded duplex sonography in impotence: significance of different flow parameters in patients and controls, Eur Urol, 21, 22, 10.1159/000474794 Pritchett, 1988, The potency-sparing radical cystectomy: does it compromise the completeness of the cancer resection?, J Urol, 140, 1400, 10.1016/S0022-5347(17)42055-6 Brendler, 1990, Local recurrence and survival following nerve-sparing radical cystoprostatectomy, J Urol, 144, 1137, 10.1016/S0022-5347(17)39675-1 Schoenberg, 1996, Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-yr follow-up, J Urol, 155, 490, 10.1016/S0022-5347(01)66429-2 Penson, 2003, General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from prostate cancer outcome study, J Clin Oncol, 21, 1147, 10.1200/JCO.2003.07.139 Leungwattanakij, 2003, Cavernous neurotomy causes hypoxia and fibrosis in rats corpus cavernosum, J Androl, 24, 239, 10.1002/j.1939-4640.2003.tb02668.x Saenz de Tejada I, Moreland RB. Physiology of erection, pathophysiology of impotence and implications of PGE1 in the control of collagen synthesis in the corpus cavernosum. In: Goldstein I, Lue TF, editors. The role of alprostadil in the diagnosis and treatment of erectile dysfunction: proceeding of a symposium, August 3–4, 1993, Brook Lodge, Kalamazoo, Michigan. Princeton, NJ: Excerpta Medica, 1993. p. 3–16. Mulhall, 2002, Erectile dysfunction after radical prostatectomy: hemodynamic profiles and their correlation with the recovery of erectile function, J Urol, 167, 1371, 10.1016/S0022-5347(05)65303-7 Montorsi, 1997, Recovery of spontaneous erectile function after nerve-sparing radical reteropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective randomized trial, J Urol, 158, 1408, 10.1016/S0022-5347(01)64227-7